| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |